Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» FDA
FDA
Theravance confirms FDA panel recommends approval of Theravance-Glaxo lung drug
Yahoo/Fly on the Wall
Tue, 09/10/13 - 04:28 pm
Theravance
FDA
advisory panel
COPD
GSK
Anoro Ellipta
Medtronic seeks FDA update on all approved pacemakers and defibrillators
Mass Device
Tue, 09/10/13 - 11:22 am
FDA
pacemakers
defibrillators
Medtronic
devices
Glaxo Declines as FDA Clears Path for Advair Rivals
Bloomberg
Tue, 09/10/13 - 10:41 am
GSK
Advair
FDA
COPD
asthma
Sandoz
Actavis
Mylan
generics
FDA scientists back accelerated approval for Roche drug to treat early-stage breast cancer
Washington Post, DC
Tue, 09/10/13 - 10:39 am
Perjeta
FDA
Roche
breast cancer
Glaxo slips, Mylan gains after FDA guides on generic Advair
The Fly on the Wall
Mon, 09/9/13 - 05:16 pm
GSK
Mylan
FDA
generics
Advair
Merck Announces FDA Acceptance of New Drug Application for Investigational Fertility Treatment
Yahoo
Mon, 09/9/13 - 09:24 am
Merck
FDA
Fertility
corifollitropin alfa
Endo Health says FDA agreed to review its application for the testosterone injection Aveed
Yahoo/AP
Fri, 09/6/13 - 08:57 am
FDA
Endo Health Solutions
testosterone
Aveed
Safety Concerns May Prevent FDA Approval Of Ligand's Drug Aprela
Seeking Alpha
Tue, 09/3/13 - 04:17 pm
FDA
Ligand
Aprela
menopause
post-menopausal osteoporosis
Simultaneous Applications Submitted to EMA and FDA for Siltuximab for the Treatment of Multicentric Castleman Disease, a Rare Blood Disorder
Reuters
Tue, 09/3/13 - 10:43 am
EMA
FDA
siltuximab
multicentric Castleman disease
These 2 Companies Are the Biggest Winners of the FDA's Breakthrough Designation
Motley Fool
Tue, 09/3/13 - 09:33 am
FDA
breakthrough therapies
ibrutinib
Pharmacyclics
JNJ
Novartis
LDK378
serelaxin
daratumumab
Genmab
FDA clears 3D-printed skull fillers by Tissue Regeneration Systems
Mass Device
Fri, 08/30/13 - 09:36 am
FDA
Tissue Regenerations Systems
skull fillers
devices
Novartis' MS drug Gilenya tied to rare brain infection
Fierce Pharma
Fri, 08/30/13 - 09:32 am
Novartis
Gilenya
MS
multiple sclerosis
PML
FDA
New FDA Guidelines Hit This Company Hard
Motley Fool
Fri, 08/30/13 - 08:47 am
FDA
Allergan
generics
Restasis
Third Obesity Drug Moves Closer to FDA Approval
Motley Fool
Thu, 08/29/13 - 05:05 pm
obesity
FDA
Orexigen
Contrave
Belviq
Qsymia
Vivus
Arena Pharmaceuticals
FDA grants priority review to blood cancer treatment from Pharmacyclics
Yahoo/AP
Thu, 08/29/13 - 09:07 am
FDA
Pharmacyclics
Janssen
JNJ
ibrutinib
mantle cell lymphoma
chronic lymphocytic leukemia
Alimera, pSivida Eye Drug Warrants FDA Approval On Third Try
TheStreet.com
Wed, 08/28/13 - 09:42 am
Alimera
pSivida
FDA
drug approvals
Iluvien
diabetic macular edema
3 PDUFA Dates That Will Kick Off 2014
Motley Fool
Tue, 08/27/13 - 05:34 pm
FDA
diabetes
Forixga
Bristol-Myers Squibb
AstraZeneca
Biomarin
Vimizim
Amylin
metreleptin
Tiny Catalyst soars after rare disease drug scores 'breakthrough' at FDA
Fierce Biotech
Tue, 08/27/13 - 11:01 am
Catalyst Pharmaceutical Partners
Firdapse
Biomarin
FDA
breakthrough therapies
Lambert-Eaton myasthenic syndrome
What Does The FDA's Breakthrough Designation Mean For Investors?
Seeking Alpha
Mon, 08/26/13 - 01:28 pm
FDA
breakthrough therapies
AbbVie
Alexion
Ariad Pharmaceuticals
Biomarin
Bristol-Myers Squibb
SynaGeva BioPharma
GSK
JNJ
Merck
Novartis
Pharmacyclics
Pfizer
Vertex Pharmaceuticals
daratumumab
ibrutinib
Kalydeco
lambrolizumab
palbociclib
LDK378
SD-101
obinutuzumab
serelaxin
asfotase alfa
bimagrumab
drisapersen
sebelipase alfa
Ceptaris wins FDA OK for lymphoma gel, clears path to $250M Actelion buyout
Fierce Biotech
Mon, 08/26/13 - 09:33 am
Actelion
FDA
Ceptaris
Valchlor
cutaneous T-cell lymphoma
Pages
« first
‹ previous
…
354
355
356
357
358
359
360
361
362
…
next ›
last »